Published in Vaccine Weekly, September 3rd, 2008
"The worldwide value of Hib vaccination for reducing Hib disease burden and carriage is reviewed," wrote B.D. Gessner and colleagues.
The researchers concluded: "Using comparisons of data for pneumococcus versus Hib, the article concludes that epidemiological and biological differences between these pathogens will complicate efforts to use results from the Hib vaccine experience to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly